Gianpaolo Reboldi

InstitutionUniversity of Perugia
AddressPerugia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 3 publications in June 2021
    All Publications
    Bar chart showing 173 publications over 20 distinct years, with a maximum of 17 publications in 2010
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Angeli F, Reboldi G, Verdecchia P. SARS-CoV-2 infection and ACE2 inhibition. J Hypertens. 2021 08 01; 39(8):1555-1558. PMID: 34188002.
      Citations: 2     Fields:    Translation:Humans
    2. Quintaliani G, Nordio M, Reboldi G, Aucella F, Brunori G. [Nephrology: where we stand and where we should go]. G Ital Nefrol. 2021 Jun 24; 38(3). PMID: 34169689.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Onder G, Olimpieri PP, Celant S, Di Lenarda A, Ambrosio G, Reboldi G, Gensini G, Colatrella A, Palmer K, Gabrielli D, Russo P. Under-prescription of direct oral anticoagulants for treatment of non-valvular atrial fibrillation and venous thromboembolism in the COVID-19 lockdown period. Eur J Prev Cardiol. 2021 Jun 21. PMID: 34151366.
      Citations:    Fields:    
    4. Angeli F, Reboldi G, Verdecchia P. Ageing, ACE2 deficiency and bad outcome in COVID-19. Clin Chem Lab Med. 2021 06 14; 59(10):1607-1609. PMID: 34118797.
      Citations: 2     Fields:    Translation:Humans
    5. Robinson BM, Guedes M, Alghonaim M, Cases A, Dasgupta I, Gan L, Jacobson SH, Kanjanabuch T, Kim YL, Kleophas W, Labriola L, Perlman RL, Reboldi G, Srivatana V, Suri RS, Tsuruya K, Torres PU, Pisoni RL, Pecoits-Filho R. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion. Kidney Med. 2021 Jul-Aug; 3(4):619-634. PMID: 34007963.
      Citations: 1     
    6. Angeli F, Spanevello A, Reboldi G, Visca D, Verdecchia P. SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med. 2021 06; 88:1-8. PMID: 33966930.
      Citations: 8     Fields:    Translation:Humans
    7. Brunori G, Reboldi G, Aucella F. Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine. Kidney Blood Press Res. 2021; 46(1):11-16. PMID: 33517338.
      Citations: 2     Fields:    Translation:Humans
    8. Nordio M, Reboldi G, Di Napoli A, Quintaliani G, Alberici F, Postorino M, Aucella F, Messa P, Brunori G. Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey. J Nephrol. 2021 04; 34(2):325-335. PMID: 33387336.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    9. Angeli F, Verdecchia P, Reboldi G. RAAS Inhibitors and Risk of Covid-19. N Engl J Med. 2020 Nov 12; 383(20):1990-1991. PMID: 33108102.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    10. Quintaliani G, Reboldi G, Di Napoli A, Nordio M, Limido A, Aucella F, Messa P, Brunori G. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology. J Nephrol. 2020 08; 33(4):725-736. PMID: 32621109.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    11. Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G, Feci D, Reboldi G, Fabbri LM, Verdecchia P. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020 08; 78:101-106. PMID: 32586646.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    12. Verdecchia P, Angeli F, Reboldi G. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus. J Hypertens. 2020 06; 38(6):1190-1191. PMID: 32371811.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    13. Verdecchia P, Reboldi G, Cavallini C, Mazzotta G, Angeli F. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. G Ital Cardiol (Rome). 2020 May; 21(5):321-327. PMID: 32310915.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    Reboldi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (141)
    Explore
    _
    Co-Authors (51)
    Explore
    _
    Similar People (60)
    Explore
    _